These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 16500886)

  • 1. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension.
    Kwon YI; Vattem DA; Shetty K
    Asia Pac J Clin Nutr; 2006; 15(1):107-18. PubMed ID: 16500886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.
    McCue P; Kwon YI; Shetty K
    Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of Ginkgo biloba L. leaves in the management of hyperglycemia and hypertension using in vitro models.
    Pinto Mda S; Kwon YI; Apostolidis E; Lajolo FM; Genovese MI; Shetty K
    Bioresour Technol; 2009 Dec; 100(24):6599-609. PubMed ID: 19665890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of cranberry-based herbal synergies for diabetes and hypertension management.
    Apostolidis E; Kwon YI; Shetty K
    Asia Pac J Clin Nutr; 2006; 15(3):433-41. PubMed ID: 16837438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies of Gynura divaricata (L.) DC extracts as inhibitors of key enzymes relevant for type 2 diabetes and hypertension.
    Wu T; Zhou X; Deng Y; Jing Q; Li M; Yuan L
    J Ethnopharmacol; 2011 Jun; 136(2):305-8. PubMed ID: 21570455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension.
    Kwon YI; Jang HD; Shetty K
    Asia Pac J Clin Nutr; 2006; 15(3):425-32. PubMed ID: 16837437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro.
    Ademiluyi AO; Oboh G
    Exp Toxicol Pathol; 2013 Mar; 65(3):305-9. PubMed ID: 22005499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved alpha-amylase and Helicobacter pylori inhibition by fenugreek extracts derived via solid-state bioconversion using Rhizopus oligosporus.
    Randhir R; Shetty K
    Asia Pac J Clin Nutr; 2007; 16(3):382-92. PubMed ID: 17704018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shaddock peels (Citrus maxima) phenolic extracts inhibit α-amylase, α-glucosidase and angiotensin I-converting enzyme activities: a nutraceutical approach to diabetes management.
    Oboh G; Ademosun AO
    Diabetes Metab Syndr; 2011; 5(3):148-52. PubMed ID: 22813568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenolic-rich extracts from selected tropical underutilized legumes inhibit α-amylase, α-glucosidase, and angiotensin I converting enzyme in vitro.
    Ademiluyi AO; Oboh G
    J Basic Clin Physiol Pharmacol; 2012 Jan; 23(1):17-25. PubMed ID: 22865445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibitory potential of selected Malaysian plants against key enzymes involved in hyperglycemia and hypertension.
    Loh SP; Hadira O
    Malays J Nutr; 2011 Apr; 17(1):77-86. PubMed ID: 22135867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenolic-linked variation in strawberry cultivars for potential dietary management of hyperglycemia and related complications of hypertension.
    Cheplick S; Kwon YI; Bhowmik P; Shetty K
    Bioresour Technol; 2010 Jan; 101(1):404-13. PubMed ID: 19695871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionality of bioactive compounds in Brazilian strawberry (Fragaria x ananassa Duch.) cultivars: evaluation of hyperglycemia and hypertension potential using in vitro models.
    da Silva Pinto M; Kwon YI; Apostolidis E; Lajolo FM; Genovese MI; Shetty K
    J Agric Food Chem; 2008 Jun; 56(12):4386-92. PubMed ID: 18522404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide.
    Subramanian R; Asmawi MZ; Sadikun A
    Acta Biochim Pol; 2008; 55(2):391-8. PubMed ID: 18511986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside-induced lipid peroxidation in rat pancreas by water extractable phytochemicals from some tropical spices.
    Adefegha SA; Oboh G
    Pharm Biol; 2012 Jul; 50(7):857-65. PubMed ID: 22480175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension.
    Kwon YI; Apostolidis E; Shetty K
    Bioresour Technol; 2008 May; 99(8):2981-8. PubMed ID: 17706416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-oxidant, anti-glycant, and inhibitory activity against α-amylase and α-glucosidase of selected spices and culinary herbs.
    Cazzola R; Camerotto C; Cestaro B
    Int J Food Sci Nutr; 2011 Mar; 62(2):175-84. PubMed ID: 21118052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes.
    Trinh BTD; Staerk D; Jäger AK
    J Ethnopharmacol; 2016 Jun; 186():189-195. PubMed ID: 27041401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory activity on type 2 diabetes and hypertension key-enzymes, and antioxidant capacity of Veronica persica phenolic-rich extracts.
    Sharifi-Rad M; Tayeboon GS; Sharifi-Rad J; Iriti M; Varoni EM; Razazi S
    Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):80-5. PubMed ID: 27262808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
    Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
    BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.